Allergan Breast Implant Lawsuit in Nebraska

Time limits apply in Nebraska. Find out if you still qualify.

Free Case Review

Start Your Free Review

Answer 2-3 quick questions to review your potential case.

Researched By
People's Justice Research Team

Verified against court records, regulatory records, and peer-reviewed research.

Last reviewed: June 11, 2026How we research

Last reviewed against primary sources: June 11, 2026

Statute of Limitations

Nebraska: 4 years from discovery for product liability (Neb. Rev. Stat. § 25-224)

4 years from BIA-ALCL diagnosis or discovery of BIOCELL injury connection

Filing Venue

Where to File in Nebraska

Nebraska has a 4-year product liability statute under Neb. Rev. Stat. § 25-224, applying from the date of discovery. Nebraska plaintiffs file in MDL 2921 in the District of New Jersey. Omaha and Lincoln plastic surgery practices placed Allergan BIOCELL products during the 2005–2019 period. Nebraska's 4-year window means BIA-ALCL diagnoses from 2022 onward are within the limitations period for Nebraska claimants.

Nebraska Data

Exposure in Nebraska

Source: FDA MAUDE Database

Source: FDA Adverse Event Reporting System